Sign In
Get Clay Free →

Suggestions

    Laura Gill

    Key Account Manager- Rare Disease- Hematology. Oncology. Pathology

    Laura Gill is a Hemolytic Anemia Specialist at Agios Pharmaceuticals, where she focuses on the treatment and management of hemolytic anemias. Her expertise is particularly relevant in the context of developing therapies for conditions like pyruvate kinase deficiency, which is a type of hereditary hemolytic anemia.

    In her role, Gill is involved in both clinical and commercial aspects of hematology, working closely with healthcare professionals to ensure effective patient care and treatment options. Her background includes significant experience in the medical field, which has led to positive recommendations from colleagues who commend her knowledge and motivation in achieving goals related to patient outcomes and sales strategies within the pharmaceutical industry.34

    Gill's professional journey reflects a commitment to advancing treatment options in hematology, particularly through her contributions at Agios Pharmaceuticals, a company known for its focus on innovative therapies for rare diseases.12

    Highlights

    Aug 11 · researchgate.net
    (PDF) Targeting Menin and CD47 to Address Unmet Needs in Acute ...
    Dec 9 · pe-online.org
    [PDF] Program Session Title Paper Title First Name Last Name ... - PE-online
    Dec 7 · hematology.org
    [PDF] 65th ASH® Annual Meeting and Exposition
    British Journal of Haematology | Wiley Online Library

    Related Questions

    What are Laura Gill's main responsibilities at Agios Pharmaceuticals?
    Has Laura Gill published any research on hemolytic anemia?
    What is Laura Gill's educational background?
    How long has Laura Gill been working at Agios Pharmaceuticals?
    What are some notable projects Laura Gill has been involved in?
    Laura Gill
    Laura Gill, photo 1
    Laura Gill, photo 2
    Get intro to Laura
    Add to my network

    Location

    United States